Pharmarise Holdings Corporation provided consolidated earnings guidance for the fiscal year ending May 31, 2024. For the period, the company expects net sales to be JPY 53,546 million, operating profit to be JPY 1,477 million, profit attributable to owners of parent to be JPY 449 million and earnings per share to be JPY 41.99.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
634 JPY | -0.16% | 0.00% | -3.94% |
1st Jan change | Capi. | |
---|---|---|
-3.94% | 44.43M | |
-13.98% | 7.92B | |
+21.46% | 1.17B | |
-8.81% | 348M | |
+6.93% | 281M | |
+8.89% | 224M | |
-48.81% | 77.03M | |
-31.19% | 66.07M | |
+37.66% | 63.97M |
- Stock Market
- Equities
- 2796 Stock
- News Pharmarise Holdings Corporation
- Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024